BioCentury
ARTICLE | Company News

Kinaxo, Daiichi Sankyo deal

October 4, 2010 7:00 AM UTC

Kinaxo will use its Cellular Target Profiling, KinAffinity and PhosphoScout proteomic profiling technologies to support development of undisclosed targeted cancer drugs from Daiichi Sankyo. Cellular T...